Stomach News and Research

RSS

New minimally invasive surgery - flexible transgastric peritoneoscopy, or FTP

Surgeries performed with specialized medical devices requiring only small incisions, called laparoscopic surgery, have many advantages over traditional open surgery, including less pain, fewer complications and quicker recoveries.

7 Jul 2004

Even in the middle of a heart attack, women are less likely than men to think their symptoms are heart-related

Most people assume that the typical heart attack patient is male, says René Martin, R.N., Ph.D., of the University of Iowa, so women and the people around them tend to look for other explanations of their symptoms, such as stomach problems.

2 Jul 2004

Four most common cancers accounted for over half of the 225,000 new cases of malignant cancer registered in England in 2001

The four most common cancers - breast, lung, colorectal and prostate - accounted for over half of the 225,000 new cases of malignant cancer (excluding non-melanoma skin cancer) registered in England in 2001.

30 Jun 2004

Nighttime surge of ghrelin may point to new targets for treating obesity

UCLA scientists have discovered that lean people experience a huge nighttime surge of ghrelin — the hormone that stimulates hunger — but obese people do not.

29 Jun 2004

Oral allergy syndrome, allergic response from fruit

For some of the nation's 35.9 million hay fever sufferers enjoying one of summer's fresh peaches or a juicy tomato may cause additional discomfort.

25 Jun 2004

Potential new strategy for blocking tumor growth

Targeting a master molecule that helps cancer cells survive when blood oxygen levels are low may offer a potentially powerful strategy for blocking tumor growth, say researchers at The University of Texas M. D. Anderson Cancer Center.

16 Jun 2004

Miniature ammonia sensor which detects ammonia in three steps

Dutch researcher Björn Timmer has developed a miniature ammonia sensor which detects ammonia in three steps. The sensor uses very small quantities of a reagent and is cheap to use.

15 Jun 2004

Retirees taking COX-2 anti-inflammatory drugs on a long-term basis also take aspirin therapy

Findings reported in a study published today in the Archives of Internal Medicine found that over half of patients within a predominantly retiree population taking COX-2 anti-inflammatory drugs on a long-term basis were also taking aspirin therapy for its cardio-protective benefit.

14 Jun 2004

Common weeds may be better than herbal cousins for preventing and curing a host of diseases

Unwanted, pulled or poisoned, the lowly weed is sometimes better than its highly touted “herbal” cousins for preventing and curing a host of diseases, according to University of Florida research.

10 Jun 2004

Non-aspirin pain drugs may help men with recurrent prostate cancer

Early results from a University of North Carolina at Chapel Hill School of Medicine study may determine if drugs called Cox-2 inhibitors, a newer type of non-aspirin pain medicine now widely prescribed for arthritis symptoms, may benefit men with recurrent prostate cancer.

10 Jun 2004

SU11248 proves effective in the treatment of gastrointestinal stromal tumors

A drug originally developed to block the formation of blood vessels in tumors has been shown to overcome resistance to treatment with Gleevec in patients with gastrointestinal stromal tumors (GIST).

9 Jun 2004

Researchers win Kaye prize for gastro-retentive sustained release drug delivery system

Despite advances made in "sustained delivery" drug delivery technologies in recent years, a problem still persists in trying to obtain controlled release of a wide variety of medications that have only a "narrow absorption window" in the upper part of the intestines. That is, these drugs are absorbed rather quickly after being swallowed, negating the beneficial effects of "once-a-day" medication.

9 Jun 2004

UK company to diagnose disease by breath test

The latest spin-out company from Oxford University, Oxford Medical Diagnostics Ltd, hopes to develop a way of diagnosing disease simply by testing someone's breath.

7 Jun 2004

Combination treatment may help type 2 diabetes patients

New research presented by Peter Weissman, M.D., from the University of Miami, at the 64th Annual Scientific Sessions of the American Diabetes Association shows that combination treatment with rosiglitazone maleate and metformin significantly improves certain markers of cardiovascular disease risk in patients with type 2 diabetes compared to metformin alone.

6 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

Cancer rates falling in the US

The nation's leading cancer organizations report that Americans' risk of getting and dying from cancer continues to decline and survival rates for many cancers continue to improve.

3 Jun 2004

Disease-causing microbes found in baby food

Enterobacter sakazakii has been found in powdered infant formula before, but a new UK study is the first to detect it in dried infant food.

3 Jun 2004

FDA investigates school lunch illness in Massachusetts

The U.S. Food and Drug Administration (FDA), the Massachusetts Department of Public Health and the U.S. Centers for Disease Control and Prevention are actively investigating what may have caused four outbreaks of illnesses in children related to meals served at several schools in Massachusetts.

3 Jun 2004

'somatoform', or 'psychosomatic', disorders are among the most common psychiatric disorders found in general practice

A study from the Netherlands has shown that ‘somatoform’, or ‘psychosomatic’, disorders are among the most common psychiatric disorders found in general practice. At least one out of six patients seen by a general practitioner has a somatoform disorder.

2 Jun 2004

BioSante publishes oral insulin study

BioSante Pharmaceuticals, Inc. has announced the publication of positive results of a preclinical study of its proprietary calcium phosphate nanoparticle (CAP) delivery system for the oral delivery of insulin in the June 11 issue of the peer-reviewed International Journal of Pharmaceutics.

2 Jun 2004